AlphaC-conotoxin PrXA: a new family of nicotinic acetylcholine receptor antagonists.
We have purified a novel paralytic peptide with 32 AA and a single disulfide bond from the venom of Conus parius, a fish-hunting species. The peptide has the following sequence: TYGIYDAKPOFSCAGLRGGCVLPONLROKFKE-NH2, where O is 4-trans-hydroxyproline. The peptide, designated alphaC-conotoxin PrXA (alphaC-PrXA), is the defining member of a new, structurally distinct family of Conus peptides. The peptide is a competitive nAChR antagonist; all previously characterized conotoxins that competitively antagonize nAChRs are structurally and genetically unrelated. (Most belong to the alpha- and alphaA-conotoxin families.) When administered to mice and fish in vivo, alphaC-PrXA caused paralysis and death. In electrophysiological assays, alphaC-PrXA potently antagonized mouse muscle nicotinic acetylcholine receptors (nAChRs), with IC50 values of 1.8 and 3.0 nM for the adult (alpha1beta1 epsilondelta subunits) and fetal (alpha1beta1 gammadelta subunits) muscle nAChR subtypes, respectively. When tested on a variety of ligand-gated and voltage-gated ion channels, alphaC-PrXA proved to be a highly specific inhibitor of the neuromuscular nAChR. The peptide competes with alpha-bungarotoxin for binding at the alpha/delta and alpha/gamma subunit interfaces of the nAChR, with higher affinity for the alpha/delta subunit interface. AlphaC-PrXA is strikingly different from the many conopeptides shown to be nicotinic antagonists; it is most similar in its general biochemical features to the snake toxins known as Waglerins.
Jimenez
Elsie C
EC
Department of Biology, University of Utah, Salt Lake City, Utah 84112, USA.
Olivera
Baldomero M
BM
Teichert
Russell W
RW
D000595:Amino Acid Sequence; D000818:Animals; D020916:Conotoxins / Q000737:chemistry / Q000302:isolation & purification* / Q000633:toxicity*; D052078:Conus Snail; D004305:Dose-Response Relationship, Drug; D005399:Fishes; D020128:Inhibitory Concentration 50; D051379:Mice; D018482:Muscle, Skeletal / Q000187:drug effects / Q000196:embryology; D018733:Nicotinic Antagonists / Q000737:chemistry / Q000302:isolation & purification* / Q000633:toxicity*; D009865:Oocytes / Q000187:drug effects; D010243:Paralysis / Q000139:chemically induced; D010455:Peptides / Q000737:chemistry; D011978:Receptors, Nicotinic / Q000378:metabolism*; D016415:Sequence Alignment; D014981:Xenopus
D020916:Conotoxins; D018733:Nicotinic Antagonists; D010455:Peptides; D011978:Receptors, Nicotinic; C522762:alphaC-conotoxin PrXA